mirror of
https://github.com/msberends/AMR.git
synced 2026-11-16 06:30:48 +01:00
Return the serovar in mo_shortname() for Salmonella, keep Salmonella groups apart from streptococci, abbreviate all Lancefield groups, and apply the Typhi rule in mdro() (#341)
This commit is contained in:
1 parent
08fd165a60
commit
3b8b213616
7 files changed
+60
-9
No files matched your search
@@ -1,7 +1,12 @@
|
||||
# AMR 3.1.0.9014
|
||||
# AMR 3.1.0.9015
|
||||
|
||||
This version fixes a critical bug in WISCA that biased all coverage estimates of `wisca()` and `antibiogram(..., wisca = TRUE)` downwards since AMR 3.0.0. Users are strongly advised to re-run their WISCA analyses.
|
||||
|
||||
### Breaking
|
||||
* `mo_shortname()` now returns the serovar for *Salmonella* serovars, e.g., `"S. Typhi"` and `"S. Goldcoast"` instead of `"S. enterica"`. As this is the default for `bug_drug_combinations()` and short names in `antibiogram()`, serovars are no longer merged in their results. Use `FUN = function(x) paste(mo_genus(x), mo_species(x))` in `bug_drug_combinations()` to group them by species (#341)
|
||||
* `mo_shortname()` now returns e.g. `"S. Group B"` for *Salmonella* groups instead of the abbreviations of streptococci, such as `"GBS"`, so that they are no longer merged with streptococci in `bug_drug_combinations()` and `antibiogram()`. *Streptococcus* groups E, I, J and L are now also abbreviated, e.g., `"GES"`, and `"B_STRPT_ABCG"` now returns `"S. Group A, B, C, G"` instead of the malformed `"GA, B, C, GS"` (#341)
|
||||
* `mdro()` now applies the rule for *Salmonella* Typhi in the EUCAST guidelines, i.e., resistance to carbapenems (and fluoroquinolones in `"EUCAST3.1"`). This rule never applied before, so these isolates were wrongly classified as negative (#341)
|
||||
|
||||
### Changed
|
||||
* WISCA (`wisca()` and `antibiogram(..., wisca = TRUE)`)
|
||||
* Fixed a critical bug that systematically underestimated the coverage of every WISCA since AMR 3.0.0. Pathogens absent from a syndromic group, and pathogens without any test result for a regimen, were still included in the model with only prior information: each added a prior weight of 1 to the pathogen incidence, and untested pathogens kept their full incidence weight while counting as about 50% susceptible. The bias was largest for stratified analyses (e.g., up to 14 percentage points for meropenem in random strata of `example_isolates`). Now, only pathogens that occur in a group and have at least one test result for the regimen are included. Please re-run all WISCA analyses (#337)
|
||||
|
||||
Reference in new issue
Block a user